Trinity Capital Inc. - 7.875% Notes Due 2029 Stock (NASDAQ: TRINI)

Latest news for Trinity Capital Inc. - 7.875% Notes Due 2029 (NASDAQ:TRINI) Stock

Trinity Capital Inc. - 7.875% Notes Due 2029

Trinity Acquisition Corporation

Trinity Bank NA

Trinity Biotech plc - American Depositary Shares

Trinity Biotech PLC

Trinity Capital Inc

Trinity Capital Inc. - 7.00% Notes Due 2025

Trinity Capital Inc. - 7.875% Notes due 2029

TRINITY EXPL & PROD PLC by Trinity Exploration & Production PLC

Trinity Exploration & Production PLC

Trinity Industries Inc

TRINITY PETE TRUST CBI by Trinity Petroleum Trust

Trinity Petroleum Trust

TRINITY PLACE HLDGS INC by Trinity Place Holdings Inc.

Trinity Place Holdings Inc

In a recent revelation, former House Speaker Nancy Pelosi has unveiled details of a phone conversation she had with then-President Donald Trump prior to his first impeachment.
What Happened: An excerpt from Pelosi&#8217;s new book, &#8220;The Art of Power,&#8221; discussed during a <a href="https://edition.cnn.com/2024/08/05/politics/video/donald-trump-phone-call-first-impeachment-nancy-pelosi-ebof-digvid">CNN</a> interview on Friday, sheds light on a phone call she received from Trump ahead of his first impeachment proceedings.
Trump purportedly told Pelosi, &#8220;There's no reason to impeach me,&#8221; and insisted he had been an effective president. Pelosi wrote that Trump&#8217;s demeanor became &#8220;increasingly whiny&#8221; as the conversation unfolded.
Pelosi recounted that the former president told her, &#8220;I&#8217;ve done a great job as president&#8230; It&#8217;s very, very unfair.&#8221;
See Also: <a href="https://www.benzinga.com/markets/cannabis/24/08/40158903/terrible-plan-billionaire-ken-griffin-donates-12m-to-defeat-floridas-cannabis-legalization-measu?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">&#8221;Terrible Plan&#8217;: Billionaire Ken Griffin Donates $12M To Defeat Florida&#8217;s Cannabis Legalization Measure</a>
Pelosi, when asked by CNN&#8217;s Dana Bash why she chose to disclose this private conversation, said it was &#8220;the basis of how to go forward,&#8221; indicating the impeachment proceedings.
Why It Matters: This revelation comes amidst a backdrop of political tension. In July, Pelosi was one of the key figures <a href="https://www.benzinga.com/general/politics/24/07/39844101/pelosi-tells-biden-he-cant-beat-trump-shell-do-everything-in-her-power-to-prevent-2024-run">urging President Joe Biden to step aside</a> in the 2024 White House race. Around the same time, Trump <a href="https://www.benzinga.com/news/24/07/39853222/trump-blasts-crazy-nancy-pelosi-vows-to-end-inflation-and-claims-kim-jong-un-misses-him-in-rnc-addre">criticized Pelosi</a> during his speech at the Republican National Convention, accusing Democrats of using the justice system as a political weapon.
Despite Trump&#8217;s <a href="https://www.benzinga.com/news/24/07/39656091/weekly-politics-round-up-trumps-controversial-remarks-about-biden-pelosis-stock-trades-and-president">unfounded claims</a> about forcing Biden out of the presidential race, Biden confirmed his continued participation. However, Pelosi later <a href="https://www.benzinga.com/general/politics/24/08/40175334/pelosi-says-president-biden-should-be-added-to-mount-rushmore-after-reportedly-pushing-for-his-o">advocated for Biden&#8217;s recognition</a> on Mount Rushmore, despite her earlier push for his withdrawal from the race.
Meanwhile, recent <a href="https://www.benzinga.com/news/24/08/40147712/kamala-harris-takes-the-lead-in-eight-new-national-polls">national polls</a> show Kamala Harris leading over Trump, indicating a potentially heated race for the 2024 presidency.
Photo Courtesy: Gage Skidmore Via Wikimedia Commons
Did You Know?
<ul>
<li>Congress Is Making Huge Investments. <a href="https://www.benzinga.com/gov-trades">Get Tips On What They Bought And Sold Ahead Of The 2024 Election With Our Easy-to-Use Tool</a></li>
</ul>
This story was generated using <a href="https://www.benzinga.com/author/benzinga-neuro">Benzinga Neuro</a> and edited by <a href="https://www.benzinga.com/author/shivdeep-dhaliwal" target="_blank" rel="noreferrer noopener">Shivdeep Dhaliwal</a>

News

Politics

General

Trump Was 'Whiny' In Pre-Impeachment Call To Pelosi Says Former House Speaker In New Book: 'It's Very, Very Unfair'

Barclays analyst Andrew Mok maintains Alignment Healthcare (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALHC#NASDAQ">ALHC</a>) with a Underweight and raises the price target from $4.5 to $7.

Price Target

Analyst Ratings

ALHC

Barclays Maintains Underweight on Alignment Healthcare, Raises Price Target to $7

Barclays analyst Steven Valiquette maintains Owens &amp; Minor (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OMI#NYSE">OMI</a>) with a Equal-Weight and lowers the price target from $23 to $18.

Barclays Maintains Equal-Weight on Owens & Minor, Lowers Price Target to $18

Barclays analyst Gena Wang maintains Regenxbio (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RGNX#NASDAQ">RGNX</a>) with a Overweight and lowers the price target from $55 to $50.

RGNX

Barclays Maintains Overweight on Regenxbio, Lowers Price Target to $50

As Ohio begins&nbsp;<a href="https://www.benzinga.com/markets/cannabis/24/08/40172821/its-official-ohio-begins-recreational-cannabis-sales-on-tuesday-heres-where-and-how-you-know-the">recreational cannabis sales</a> on August 6, Pablo Zuanic, senior analyst at Zuanic &amp; Associates&nbsp;has initiated coverage of Vext Science (OTC: <a class="ticker" href="https://www.benzinga.com/stock/vextf#OTC">VEXTF</a>) with an Overweight rating, highlighting the company&#39;s significant growth potential.
Zuanic calculates that Vext has the most EBITDA torque among the 12 public multi-state operators (MSOs) in Ohio, projecting Vext&#39;s EBITDA could grow six-fold by CY26, taking CY23 as the base year.
<h3>Ohio Market Projections: $2.36B In 2026</h3>
<ul>
<li>The Ohio market is expected to grow substantially with the start of recreational sales, potentially expanding 3-4 times the current medical market size.</li>
<li>Zuanic projects the Ohio market to reach a $1.85 billion annual run rate by the end of 2025 and $2.36 billion by the end of 2026.</li>
<li>This growth trajectory is based on conservative estimates, with per capita spending expected to reach $150 by the end of the first year of recreational sales and $200 by 4Q26.</li>
</ul>
<h3>Valuation And Market Performance</h3>
Despite trading mostly in line with the MSO average, Vext&#39;s stock valuation does not yet reflect the expected EBITDA ramp. &quot;The stock valuation does not reflect the EBITDA ramp,&quot; notes Zuanic. The report underscores that Vext&rsquo;s current valuation is compelling, particularly when considering the<a href="https://www.benzinga.com/markets/cannabis/24/05/38760793/this-cannabis-co-expects-significant-growth-once-ohios-retail-market-launches-reports-slight-yoy"> projected upside</a>.
Zuanic&#39;s analysis shows that Vext could experience a 471% increase in value creation, compared to other MSOs like Acreage (OTCQX: <a class="ticker" href="https://www.benzinga.com/stock/acrhf#OTCQX">ACRHF</a>) at 275%, Cannabist (CSE: CCHW) at 185%, and Ascend (OTC: <a class="ticker" href="https://www.benzinga.com/stock/aawh#OTC">AAWH</a>) at 62%.
Read Also:&nbsp;<a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/06/39470114/debt-deadline-looms-how-cannabis-companies-financial-health-could-impact-your-portf">Debt Deadline Looms: How Cannabis Companies&#39; Financial Health Could Impact Your Portfolio</a>
<h3>Strategic Operations And Expansion</h3>
Vext operates a 25K sq ft<a href="https://www.benzinga.com/markets/cannabis/24/05/39064070/cannabis-producer-vext-reports-yoy-decline-in-q1-announces-2m-standby-credit-facility-ahead-of-o"> cultivation facility </a>and two dispensaries in Ohio, with plans to acquire two more dispensaries by the end of 2024. The company&rsquo;s aggressive expansion in Ohio positions it well to capitalize on the anticipated market growth.
Zuanic points out, &quot;Vext has garnered pretty good value in Ohio, being agile in acquiring licenses and independent operators.&quot;
In this analysis, Pablo Zuanic extrapolates total sales upside based on store percentage share, acknowledging that this doesn&#39;t account for location or execution. He notes that not all retailers own cultivation facilities, which could affect wholesale market share.
Additionally, MSOs like Ascend (OTC: <a class="ticker" href="https://www.benzinga.com/stock/aawh#OTC">AAWH</a>), Cresco (OTC: <a class="ticker" href="https://www.benzinga.com/stock/crlbf#OTC">CRLBF</a>), Green Thumb (OTCQX: <a class="ticker" href="https://www.benzinga.com/stock/gtbif#OTCQX">GTBIF</a>), and MariMed (OTCQB: <a class="ticker" href="https://www.benzinga.com/stock/mrmd#OTCQB">MRMD</a>) consistently outperform in other states and might do the same in Ohio, with potential expansions through M&amp;A deals.
Read Next:&nbsp;<a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/05/39076254/top-ohio-cannabis-companies-analyst-look-at-stocks-with-potential-market-cap-gains">Top Ohio Cannabis Companies: Analyst Look At Stocks With Potential Market Cap Gains</a>
These issues will be among the hot topics at the upcoming Benzinga Cannabis Capital Conference in Chicago this Oct. 8-9. Join us to get more insight into what the wave of weed legalization means for the future of investing in the&nbsp;industry. Hear directly from top executives, investors, advocates, and policymakers.&nbsp;<a href="https://www.eventbrite.com/e/benzinga-capital-conference-cannabis-fall-2024-tickets-858948065787?aff=oddtdtcreator" rel="noreferrer noopener" target="_blank">Get your tickets now</a>&nbsp;before prices go up by following&nbsp;<a href="https://www.eventbrite.com/e/benzinga-capital-conference-cannabis-fall-2024-tickets-858948065787?aff=oddtdtcreator" rel="noreferrer noopener" target="_blank">this link</a>.
Photo: AI-generated image.&nbsp;

Analyst Color

Cannabis

Penny Stocks

Guidance

Emerging Markets

Small Cap

Markets

Trading Ideas

AAWH

ACRHF

CRLBF

GTBIF

MRMD

VEXTF

The King Of Ohio's Recreational Cannabis Market?  Here's Why Investors Should Follow This Weed Stock

Barclays analyst Matt Miksic maintains Tandem Diabetes Care (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TNDM#NASDAQ">TNDM</a>) with a Overweight and raises the price target from $55 to $58.

TNDM

Barclays Maintains Overweight on Tandem Diabetes Care, Raises Price Target to $58

BIVI

Trading Halt: Halted at 7:50:00 p.m. ET - Trading Halt: Halt News Pending

Barclays analyst Ramsey El-Assal maintains TELUS Intl (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TIXT#NYSE">TIXT</a>) with a Equal-Weight and lowers the price target from $7 to $5.

TIXT

Barclays Maintains Equal-Weight on TELUS Intl, Lowers Price Target to $5

Barclays analyst Luke Sergott maintains Twist Bioscience (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TWST#NASDAQ">TWST</a>) with a Overweight and lowers the price target from $60 to $55.

TWST

Barclays Maintains Overweight on Twist Bioscience, Lowers Price Target to $55

Barclays analyst Duffy Fischer maintains Air Products &amp; Chemicals (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/APD#NYSE">APD</a>) with a Equal-Weight and raises the price target from $290 to $295.

Barclays Maintains Equal-Weight on Air Products & Chemicals, Raises Price Target to $295

Barclays analyst Julian Mitchell maintains APi Gr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/APG#NYSE">APG</a>) with a Overweight and lowers the price target from $44 to $43.

Barclays Maintains Overweight on APi Gr, Lowers Price Target to $43

Barclays analyst Julian Mitchell maintains Vontier (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VNT#NYSE">VNT</a>) with a Overweight and lowers the price target from $50 to $44.

Barclays Maintains Overweight on Vontier, Lowers Price Target to $44

Barclays analyst Raimo Lenschow maintains Appian (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APPN#NASDAQ">APPN</a>) with a Underweight and lowers the price target from $32 to $29.

APPN

Barclays Maintains Underweight on Appian, Lowers Price Target to $29

Barclays analyst Raimo Lenschow maintains Paylocity Holding (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PCTY#NASDAQ">PCTY</a>) with a Equal-Weight and lowers the price target from $160 to $156.

PCTY

Barclays Maintains Equal-Weight on Paylocity Holding, Lowers Price Target to $156

Barclays analyst Dan Levy maintains Aptiv (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/APTV#NYSE">APTV</a>) with a Overweight and lowers the price target from $105 to $100.

APTV

Barclays Maintains Overweight on Aptiv, Lowers Price Target to $100

Barclays analyst Benjamin Budish maintains Ares Management (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ARES#NYSE">ARES</a>) with a Overweight and raises the price target from $151 to $155.

ARES

Barclays Maintains Overweight on Ares Management, Raises Price Target to $155

Stocks declined <a href="https://www.benzinga.com/government/24/08/40168075/markets-are-ripe-for-negativity-but-financial-expert-urges-investors-to-pick-up-some-deals">across the board</a> on Monday as investors worried that the U.S. economy was weakening after Friday&#8217;s cooler-than-expected jobs report.
The Dow Jones Industrial Average fell 2.6%, or 1,034 points, and the S&amp;P 500 shed 3%, or 160 points, to mark their greatest one-day losses since September 2022. The tech-heavy Nasdaq Composite dropped 3.4%.
The biggest losers on the Dow were all tech stocks. Intel Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INTC#NASDAQ">INTC</a>) fell 6.38% to close at $20.11, while Apple Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>) slipped 4.82 to $209.27 and Cisco Systems Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CSCO#NASDAQ">CSCO</a>) dropped 4.11% to $44.74.
Caesars Entertainment Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CZR#NASDAQ">CZR</a>) declined 6.90% to close at $33.20 on Monday to lead losses on the S&amp;P 500. Walgreens Boots Alliance, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WBA#NASDAQ">WBA</a>) lost 6.62% to land at $10.72 while Etsy, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ETSY#NASDAQ">ETSY</a>) fell 6.57% to close at $55.45.
Read Also: <a href="https://www.benzinga.com/24/08/40170374/unwinding-of-japanese-yen-carry-trade-boosts-the-case-for-supersized-rate-cut-economist-says">Unwinding Of Japanese Yen Carry Trade Boosts The Case For &#8216;Supersized&#8217; Rate Cut, Economist Says</a>
Exchange-traded funds that track the Dow and the S&amp;P 500 also fell on Monday. The SPDR Dow Jones Industrial Average (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DIA#NYSE">DIA</a>) slipped 2.60% and the  SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) fell 2.91%.
Monday was only the 15th time in the Dow&#8217;s history that it lost more than 1,000 points in one day, according to FactSet data, CNN <a href="https://www.cnn.com/business/live-news/global-stock-markets-plunge/index.html">reported</a>.
Japanese stocks also plummeted the most in one day since 1987 as jitters over a slowing U.S. economy pulled down global markets.The Nikkei 225 index of leading stocks in Tokyo lost 4,451 points, or more than 12% to register its biggest drop ever.
Oil prices also declined as West Texas Intermediate crude futures, the U.S. benchmark, settled at $72.94 a barrel and Brent crude futures, the international benchmark, landed at $76.30 a barrel.
Traders see an 85% expectation that the Fed will cut rates by half a point the next time it meets on Sept. 18, according to the CME FedWatch Tool.
Read Now: 
<ul>
<li><a href="https://www.benzinga.com/government/24/08/40164105/potential-iranian-attack-on-israel-could-rattle-markets-what-happened-to-stocks-when-russia-invaded">Potential Iranian Attack On Israel Could Rattle Markets: What Happened To Stocks When Russia Invaded Ukraine?</a></li>
</ul>
Photo: Shutterstock

Asia

Equities

Economics

Federal Reserve

Movers

Tech

ETFs

AAPL

CSCO

SPDR Dow Jones Industrial Average ETF Trust

ETSY

INTC

Tech Stocks Lead Dow Jones Industrial Average To Largest Drop In Almost Two Years

Barclays analyst Ryan Macwilliams maintains Atlassian (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TEAM#NASDAQ">TEAM</a>) with a Overweight and lowers the price target from $275 to $250.

TEAM

Barclays Maintains Overweight on Atlassian, Lowers Price Target to $250

Barclays analyst Ramsey El-Assal maintains Automatic Data Processing (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADP#NASDAQ">ADP</a>) with a Overweight and raises the price target from $282 to $310.

Barclays Maintains Overweight on Automatic Data Processing, Raises Price Target to $310

Barclays analyst Ramsey El-Assal maintains AvidXchange Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVDX#NASDAQ">AVDX</a>) with a Overweight and lowers the price target from $14 to $10.

The Only Monthly Membership With a Positive ROI!

-

-

-

-

-

-

-

The Only Monthly Membership With a Positive ROI!

-

-

-

-

-

-

-

Comments

Trinity Capital Inc. - 7.875% Notes Due 2029

News

Latest news for Trinity Capital Inc. - 7.875% Notes Due 2029 (NASDAQ:TRINI) Stock